Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 5,310.00
+10.00 (0.19%)
Oct 10, 2025, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 509.95 billion as of October 10, 2025. Its market cap has decreased by -35.35% in one year.
Market Cap
509.95B
Enterprise Value
477.77B
Revenue
1.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,310.00
Market Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 509.95B, an increase of 973.72%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 509.95B | -9.24% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1,038.98B | -4.44% |
| Dec 29, 2022 | 1,087.24B | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | 1,048.68B | 115.45% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,545.53B |